Elspeth J Hutton
Overview
Explore the profile of Elspeth J Hutton including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
19
Citations
178
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Colman B, Sanfilippo P, Fok A, Le Nguyen M, Kini R, Chakrabarti R, et al.
J Neurol
. 2025 Jan;
272(2):108.
PMID: 39812855
Background: Idiopathic intracranial hypertension (IIH) is increasingly prevalent, yet longitudinal outcome data are scarce. This study aimed to characterise demographic and longitudinal clinical changes in a cohort of patients with...
2.
Ray J, Darby D, Butzkueven H, Matharu M, Hutton E
Neurol Sci
. 2024 Apr;
45(9):4445-4449.
PMID: 38607534
Introduction: Cognitive symptoms are reported commonly throughout all phases of a migraine; however, there is a paucity of objective cognitive profiling. Previous studies have been limited by practice effect, and...
3.
Colman B, Boonstra F, Nguyen M, Raviskanthan S, Sumithran P, White O, et al.
J Neurol Neurosurg Psychiatry
. 2023 Oct;
95(4):375-383.
PMID: 37798095
Idiopathic intracranial hypertension (IIH) is a condition of significant morbidity and rising prevalence. It typically affects young people living with obesity, mostly women of reproductive age, and can present with...
4.
Ray J, Sztal-Mazer S, Baker J, Matharu M, Hutton E
Cephalalgia
. 2023 Jun;
43(6):3331024231180562.
PMID: 37264889
Background: Calcitonin gene-related peptide monoclonal antibodies (CGRP mAb) are an effective treatment of migraine however may have possible off-target effects. Pre-clinical studies implicate CGRP in several aspects of bone turnover...
5.
Cheema S, Mehta D, Ray J, Hutton E, Matharu M
Cephalalgia
. 2023 Apr;
43(5):3331024231168089.
PMID: 37032616
Objective: To perform a systematic review and meta-analysis of the epidemiology, precipitants, phenotype, comorbidities, pathophysiology, treatment, and prognosis of primary new daily persistent headache. Methods: We searched PubMed/Medline, EMBASE, Cochrane,...
6.
Musubire A, Cheema S, Ray J, Hutton E, Matharu M
J Headache Pain
. 2023 Apr;
24(1):36.
PMID: 37016284
Background: The role of inflammation and cytokines in the pathophysiology of primary headache disorders is uncertain. We performed a systematic review and meta-analysis to synthesise the results of studies comparing...
7.
Ray J, Cheema S, Foster E, Gunasekera L, Mehta D, Corcoran S, et al.
Front Neurol
. 2022 Nov;
13:1036798.
PMID: 36408496
Objective: To assess the prevalence and burden of autonomic symptoms in migraine, and determine the relationship with migraine frequency. Background: Autonomic symptoms in migraine have been theorized to occur in...
8.
Ray J, Hutton E
Aust Prescr
. 2022 Jun;
45(3):88-92.
PMID: 35755987
Patients with a suspected change in intracranial pressure or a trigeminal autonomic cephalgia require MRI. The need for investigation for other headache disorders is guided by the clinical evaluation of...
9.
Ray J, Pham X, Foster E, Cheema S, Corcoran S, Matharu M, et al.
Cephalalgia
. 2022 Apr;
42(11-12):1274-1287.
PMID: 35469447
Background: Headache is a common presentation of postural tachycardia syndrome, yet robust prevalence data is lacking. Objectives: To undertake a systematic review and meta-analysis to estimate the prevalence of headache...
10.
Ray J, Chen Z, Ramsay G, Germaine J, Hutton E
BMJ Open
. 2022 Mar;
12(3):e059647.
PMID: 35260463
Introduction: Status migrainosus is a disabling complication of migraine, which frequently results in hospitalisation. For patients who fail to respond to simple analgesia, triptans and intravenous prochlorperazine or chlorpromazine, there...